The will need a far more rigorous controlled trial to demonstrate the efficacy and safety for FDA acceptance. It isn't clear that what they have will be accepted now by BSI after this review. It was refused before.
OSL Price at posting:
12.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)